Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 12/22/20 → 04/13/26 |
Funding
- Sanofi US Services Incorporated: $218,029.60
A Phase 3, Randomized, Double-Blind, Efficacy and Safety Study Comparing SAR442168 to Placebo in Participants with Nonrelapsing Secondary Progressive Multiple Sclerosis (HERCULES)
- Coyle, Patricia (PI)
- McLinskey, Nancy (CoPI)
- Melville, Patricia (CoPI)
- Syritsyna, Olga (CoPI)
Project: Research